Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Belgium?, 2019-04-05 08:51 (564 d 01:42 ago) – Posting: # 20126
Views: 2,072

Hello to you too, PKS,

» Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

What does your protocol say on exactly that matter?

I could be wrong, but...

Best regards,
ElMaestro

R's base package has 274 reserved words and operators, along with 1761 functions. I can use 18 of them (about 14 of them properly). I believe this makes me the Donald Trump of programming.

Complete thread:

Activity
 Admin contact
21,165 posts in 4,410 threads, 1,476 registered users;
online 7 (1 registered, 6 guests [including 4 identified bots]).
Forum time: Tuesday 10:34 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5